Authors/Disclosures
|
Andrea Martinuzzi, MD, PhD, FAAN
|
No disclosure on file |
|
Egemen Idiman, MD
|
No disclosure on file |
|
Jaskaren Dhillon, MD, MBBS
(Houston Methodist Neurology Associates - Willowbrook)
|
No disclosure on file |
|
|
No disclosure on file |
|
Shivika Chandra, MD, FAAN
(University of Texas Health Science Center at Houston)
|
The institution of Dr. Chandra has received research support from American Board of Psychiatry and Neurology Faculty Innovation in Education Award. The institution of Dr. Chandra has received research support from Michael J Fox Foundation. |
|
Jeffrey C. McClean II, MD, FAAN
(San Antonio Military Medical Center)
|
Dr. McClean has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. Dr. McClean has received personal compensation in the range of $0-$499 for serving as a Committee Member with American Academy of Neurology. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Proleta Datta, MD
(Oregon Health and Science University)
|
Dr. Datta has nothing to disclose. |
|
|
No disclosure on file |
|
Paul E. Schulz, MD
(UT Physicians)
|
Dr. Schulz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisa . |
|
|
No disclosure on file |
|
John A. Lincoln, MD, PhD
(McGovern Medical School, UTHealth)
|
The institution of Dr. Lincoln has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. Dr. Lincoln has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Lincoln has received research support from Deaprtment of Defense. The institution of Dr. Lincoln has received research support from National Institutes of Health. The institution of Dr. Lincoln has received research support from EMD-Serono. Dr. Lincoln has received intellectual property interests from a discovery or technology relating to health care. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Maria D'Angelo, MD
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Costanza Lamperti
(College of Physicians and Surgeons)
|
No disclosure on file |
|
Massimo Pandolfo, MD, FAAN
|
Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Design Therapeutics . Dr. Pandolfo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Solid Bio. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Design Therapeutics. Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics. Dr. Pandolfo has stock in Voyager Therapeutics. The institution of Dr. Pandolfo has received research support from Freidreich Ataxaia Research Alliance. Dr. Pandolfo has a non-compensated relationship as a Scientific Advisory Board with Friedreich Ataxia Research Alliance that is relevant to AAN interests or activities. Dr. Pandolfo has a non-compensated relationship as a Member-Meeting Management Committee with AAN that is relevant to AAN interests or activities. |
|
Giovanni Meola, MD, FAAN
|
No disclosure on file |
|
Olimpia Musumeci
|
No disclosure on file |
|
Antonio Toscano, MD
|
Dr. Toscano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. |
|
Carlo P. Trevisan
|
No disclosure on file |
|
Nereo Bresolin, DR
|
No disclosure on file |
|
|
No disclosure on file |